Iger Peginterferon Lambda News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Iger Peginterferon Lambda . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Iger Peginterferon Lambda Today - Breaking & Trending Today

Eiger To Discontinue Peginterferon Lambda Trial In CHD Patients; Stock Down In Premarket

Published: September 13, 2023

Eiger BioPharmaceuticals, Inc. (EIGR), a commercial-stage biopharmaceutical company focused on rare metabolic diseases, Wednesday said it has decided to discontinue the Phase 3 LIMT-2 study of peginterferon lambda in patients with chronic hepatitis delta or CHD.

Source: rttnews.com

Related Topics:

David ApelianEiger Biopharmaceuticals IncMore Such Health NewsEiger BiopharmaceuticalsData Safety Monitoring BoardPeginterferon LambdaIger Peginterferon Lambda Iger To DiscontinueHd PatientRare Metabolic